Background: Evaluation of androgen receptor (AR) and cytokeratin 20 (CK20) expression can aid in distinguishing between conventional basal cell carcinoma (characteristically AR+, CK20-) and trichoepithelioma (frequently AR-, CK20+). Within these two groups of tumors, morpheaform/infiltrative basal cell carcinoma (mBCC) and desmoplastic trichoepithelioma (DTE) are particularly challenging to differentiate both clinically and histologically. We investigated whether AR and CK20 immunostains may distinguish between mBCC and DTE.

Methods: Immunohistochemistry for AR and CK20 was performed on 15 DTEs and 31 mBCCs. Any immunoreactivity within the tumor for AR or CK20 was considered positive.

Results: AR expression was seen in 13% (2/15) of DTE and 65% (20/31) of mBCC cases (chi-square p = 0.0011). CK20-positive Mërkel cells were identified in 100% (15/15) of DTE and 3% (1/31) of mBCC (chi-square p < 0.0001). The expected pattern of AR-, CK20+ immunophenotype was present in 87% (13/15) of DTE cases. In mBCC, 61% (19/31) was AR+, CK20-. No DTE was AR+, CK20- and no mBCC was AR-, CK20+.

Conclusions: Immunohistochemical stains for AR and CK20 are useful to differentiate DTE from mBCC. The AR-, CK20+ immunophenotype is sensitive (87%) and specific for DTE (100%). The AR+, CK20- immunophenotype is specific (100%) and moderately sensitive (61%) for mBCC.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0560.2007.00783.xDOI Listing

Publication Analysis

Top Keywords

ar+ ck20-
16
basal cell
12
ar- ck20+
12
androgen receptor
8
desmoplastic trichoepithelioma
8
morpheaform/infiltrative basal
8
cell carcinoma
8
mbcc
8
ck20+ immunophenotype
8
mbcc ar-
8

Similar Publications

Clinicopathological diagnosis of axillary signet-ring cell-like/histiocytoid carcinoma: a case report and literature review.

Histol Histopathol

October 2024

Department of Pathology, Guang'an Men Hospital, China Academy of Chinese Medical Sciences, Beijing, PR China.

Objective: To explore the clinicopathological and morphological characteristics, diagnosis, differential diagnosis, treatment, and prognosis of primary signet-ring cell/histiocytoid carcinoma (SRCHC) of the axilla.

Methods: The clinical manifestations, pathomorphological characteristics, and immunohistochemical staining results of a case of primary SRCHC in the axilla were retrospectively analyzed, and the relevant literature was reviewed.

Results: The patient was a 69-year-old male.

View Article and Find Full Text PDF

Metastatic Intestinal Adenocarcinoma: A Rare Case Involving the Mandible.

Head Neck Pathol

September 2024

Department of Oral and Maxillofacial Pathology, Manipal College of Dental Sciences, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Article Synopsis
  • - A 55-year-old man had a fast-growing mass in his jaw, causing facial changes, which was diagnosed as metastatic intestinal adenocarcinoma after extensive testing.
  • - The diagnosis was confirmed through histopathological and immunohistochemical examinations, alongside PET scan results.
  • - The patient sought treatment at a government facility but lost follow-up care, which complicates management of his condition.
View Article and Find Full Text PDF

ATOH1, TFAP2B, and CEACAM6 as Immunohistochemical Markers to Distinguish Merkel Cell Carcinoma and Small Cell Lung Cancer.

Cancers (Basel)

February 2024

Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Article Synopsis
  • Merkel cell carcinoma (MCC) and small cell lung cancer (SCLC) can look similar under a microscope, complicating their diagnosis and requiring specific tests to tell them apart.* -
  • Current immunohistochemistry markers like cytokeratin 20 (CK20) and thyroid transcription factor 1 (TTF-1) are commonly used, but have limitations in sensitivity and specificity.* -
  • New candidate markers, ATOH1 and TFAP2B for MCC, and CEACAM6 for SCLC, show high specificity and sensitivity in immunostaining, suggesting their potential in improving diagnostic accuracy.*
View Article and Find Full Text PDF

Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.

Pathol Res Pract

February 2024

Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Anatomic Pathology, Precision Diagnostics & Therapeutics Program, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. Electronic address:

Introduction: Prostatic adenocarcinoma can occasionally display urothelial carcinoma morphology, which prompts immunohistochemistry (IHC) studies to determine its lineage. Typically, prostate cancer is characterized by the lack of cytokeratin (CK) 7, CK20 and high molecular weight keratin (HMWK) expression, as opposed to bladder cancer.

Methods: We report a series of 12 prostatic adenocarcinoma cases with unusual urothelial-like morphology, diagnosed at two academic institutions in Toronto between 2018 and 2023, and analyzed by immunohistochemistry for prostatic, urothelial, and neuroendocrine marker expression.

View Article and Find Full Text PDF

The relationship between various patterns of mucin-producing salivary adenocarcinomas, including invasive salivary adenocarcinomas with mucinous differentiation, such as colloid and papillary carcinomas, remains unclear. Herein, we aimed to describe the clinicopathologic characteristics, immunophenotypes, molecular underpinnings, and clinical behavior of salivary mucinous adenocarcinomas (MA) to clarify their classification. We described a broad series of colloid and papillary patterns of MAs, indicating that papillary pattern presented papillary cystic proliferation of mucinous columnar cells as salivary intraductal papillary mucinous neoplasms with recurrent AKT1 E17K mutations, whereas colloid adenocarcinomas containing large mucinous pools or lakes around the malignant epithelial nests or islands harbored BRAF V600E mutations with worse prognosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!